CALL - SPRINTER OPEN END - ABBOTT LABORATORIES Share Price

Certificat

DE000VM5KVB0

Delayed Deutsche Boerse AG 02:01:43 20/05/2024 pm IST
0.38 EUR 0.00% Intraday chart for CALL - SPRINTER OPEN END - ABBOTT LABORATORIES
Current month-40.62%
1 month-40.62%
Date Price Change
20/24/20 0.38 0.00%
17/24/17 0.38 -11.63%
16/24/16 0.43 +4.88%
15/24/15 0.41 +24.24%
14/24/14 0.33 -25.00%

Delayed Quote Deutsche Boerse AG

Last update May 20, 2024 at 02:01 pm IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer Vontobel Vontobel
WKN VM5KVB
ISINDE000VM5KVB0
Date issued 15/11/2023
Strike 100.4 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.05
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.07
Lowest since issue 0.14
Spread 0.02
Spread %5.00%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
104.1 USD
Average target price
126.1 USD
Spread / Average Target
+21.19%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW